Page last updated: 2024-08-24

duloxetine hydrochloride and Mood Disorders

duloxetine hydrochloride has been researched along with Mood Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benasi, G; Cosci, F; Fava, GA; Guidi, J; Lucente, M; Offidani, E1
Hu, D; Wurster, S1
López-Jornet, P; Silvestre, FJ; Silvestre-Rangil, J1
Brecht, S; Crucitti, A; Nilsson, M; Wernicke, J; Yang, CR; Zhang, Q1
Dundon, K; Mease, PJ; Sarzi-Puttini, P1
Bailey, KP1

Reviews

5 review(s) available for duloxetine hydrochloride and Mood Disorders

ArticleYear
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Psychotherapy and psychosomatics, 2018, Volume: 87, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Mood Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2018
Burning mouth syndrome: a review and update.
    Revista de neurologia, 2015, May-16, Volume: 60, Issue:10

    Topics: Adult; Age Distribution; Aged; Algorithms; Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Deficiency Diseases; Dentures; Duloxetine Hydrochloride; Female; Humans; Male; Menopause; Middle Aged; Mood Disorders; Nerve Fibers, Unmyelinated; Orthodontic Appliances; Sex Distribution; Sulpiride; Tongue Habits

2015
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Current medical research and opinion, 2010, Volume: 26, Issue:11

    Topics: Antidepressive Agents; Anxiety Disorders; Blood Glucose; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Glycemic Index; Humans; Hyperglycemia; Male; Middle Aged; Mood Disorders; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome

2010
Pharmacotherapy of fibromyalgia.
    Best practice & research. Clinical rheumatology, 2011, Volume: 25, Issue:2

    Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome

2011
Physical symptoms comorbid with depression and the new antidepressant duloxetine.
    Journal of psychosocial nursing and mental health services, 2003, Volume: 41, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Gastrointestinal Diseases; Humans; Mood Disorders; Norepinephrine; Pain; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep Wake Disorders; Thiophenes; Treatment Outcome

2003

Other Studies

1 other study(ies) available for duloxetine hydrochloride and Mood Disorders

ArticleYear
Hyponatremia Induced by Duloxetine: A Case Report.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2018, Aug-01, Volume: 33, Issue:8

    Topics: Aged, 80 and over; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mood Disorders; Selective Serotonin Reuptake Inhibitors

2018